我武生物 (300357)

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

ASZ

Tags

Specialized-Sophisticated-Distinctive-Innovative EnterprisesBiological ProductsSocial Security HeavyHigh-Performing StocksChiNext 200 IndexChiNext IndexChiNext Blue ChipChiNext HealthcareSZSE 300 IndexPharma & BiotechSZSE Medicine Equal Weight IndexBrand Engineering IndexPharmaceutical IndexShenzhen A-Share Pharmaceutical IndexChiNext Equal Weight IndexCSI All-share Pharmaceutical Sector IndexEmerging Technology 100 IndexSZSE 700 IndexSZSE Emerging Industries IndexSZSE 1000 IndexHangzhou Bay Area IndexSZSE 300 Return IndexCSSW Health IndexSZSE Component Index ReturnCSWD Life Sciences IndexCNI 1000 IndexBiomedicine IndexSZSE Performance IndexGrowth 40 IndexChiNext Value IndexFTSE Russell ConceptHuijin ConceptSmall-cap High Beta IndexCS High-end Manufacturing IndexVaccine & Biotech IndexChiNext Quality IndexSHS Innovative Drugs IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexCCTV 500 IndexChiNext Basic IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexCSI Yangtze River Delta IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexChiNext Low Volatility IndexCSI 500 Equal Weight IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightCS Biomedicine IndexPharmaceutical & Health 100 IndexCSI 700 IndexMid-small Cap IndexCSI 500 IndexCSI 500 IndexZhongchuang High Beta IndexZhongchuang Low Volatility IndexCSI 500 Growth Innovation IndexCSI 1000 Growth Innovation IndexCSI Life Sciences IndexSZSE 200 Return IndexSZSE 200 IndexYangtze River 100 IndexChiNext High Beta IndexZhongchuang 400 IndexCS Innovative Drugs IndexCSI 500 Smart Low Volatility IndexESG 300 IndexCR New Momentum IndexZhejiang 100 IndexChiNext Return IndexSZSE 500 IndexChiNext Emerging IndexCSI 500 ESG IndexChiNext Growth IndexSuyin Wealth Management Yangtze River Delta IndexZhejiang

K-Line Chart

No K-line data available

Company NameZhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Listing Date2014-01-21
Issue Price20.05RMB
Registered Capital52358.410k RMB
Legal RepresentativeHu Gengxi
Registered AddressNo. 636 Zhiyuan North Road, Wukang Town, Deqing County, Zhejiang Province, China
IndustryBiological Products
Main BusinessResearch, development, production, and sales of biopharmaceutical products.
Company ProfileWolwo Bio-Pharmaceutical's business objective is to become a leader and key member of the international pharmaceutical industry (e.g., elevating the company's value to the forefront of global peers) by providing society with pharmaceutical products that 'improve human quality of life and extend healthy lifespan,' while simultaneously enabling substantial development and returns for the company's shareholders and employees. Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is a high-tech biopharmaceutical listed company (Stock Code: 300357). Wolwo focuses solely on developing innovative drugs (including proven effective traditional or natural medicines, stem cell drugs) or products with similar medical functions, as well as new medical devices, that possess significant technological or market advantages. Independently researching and developing, investing in, or acquiring technologies, products, or enterprises that meet these criteria, and securing a market position protected by patents among other means, constitutes the company's fundamental product development strategy.

Stock Details

1. Key Indicators

  • Total Shares(W): 52358.40
  • Circulating A-Shares(W): 48406.42
  • Earnings Per Share(RMB): 0.6587
  • Net Assets Per Share(RMB): 5.0340
  • Operating Revenue(W RMB): 85336.04
  • Total Profit(W RMB): 39427.84
  • Net Profit Attributable to Parent(W RMB): 34486.65
  • Net Profit Growth Rate(%): 26.67
  • Weighted Return on Equity(%): 13.8000
  • Operating Cash Flow Per Share(RMB): 0.5480
  • Undistributed Profit Per Share(RMB): 3.2721
  • Capital Reserve Per Share(RMB): 0.2448

2. Main Business

The main business covers:

  • Research, production and sales of diagnostic and therapeutic products for allergic diseases

3. Company Basic Information

  • Company Name: Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
  • Listing Date: 2014-01-21
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 636 Zhiyuan North Road, Wukang Town, Deqing County, Huzhou City, Zhejiang Province
  • Website: www.wolwobiotech.com
  • Company Profile: The issuer's predecessor was Zhejiang Wolwo Biotechnology Co., Ltd., established on September 19, 2002. The issuer was established as a joint stock company through the overall change of Wolwo Co., Ltd., which contributed its audited net assets of RMB 90,380,637.31 as of December 31, 2010 as capital contribution, converted into shares at a ratio of 1:0.9958, totaling RMB 90,000,000. On February 18, 2011, the issuer obtained the "Business License" (Registration No.: 330500400002475) issued by the Huzhou Administration for Industry and Commerce of Zhejiang Province, with a registered capital of RMB 90 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Zhejiang Wolwo Management Consulting Co., Ltd. General Legal Person 20345.41 42.03
2 National Social Security Fund 112 Portfolio Social Security Fund 2608.11 5.39
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 556.20 1.15
4 Harvest Mutual Selection Equity Securities Investment Fund Class A Fund 471.18 0.97
5 Penghua Pharmaceutical Technology Equity Securities Investment Fund Class A Fund 429.86 0.89
6 China Merchants Guozheng Bio-medicine Index Securities Investment Fund (LOF) Class A Fund 390.68 0.81
7 Dacheng ChiNext Two-Year Regular Open Hybrid Securities Investment Fund Class A Fund 211.48 0.44
8 Penghua Medical Care Equity Securities Investment Fund Fund 80.84 0.17
9 Penghua Pension Industry Equity Securities Investment Fund Fund 73.47 0.15
10 Dacheng Quality Medical Equity Securities Investment Fund Class A Fund 58.62 0.12

5. Concept Sectors

  • Artificial Intelligence
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Heavy Holdings by Social Security Fund
  • Specialized, Refined, Special and New Enterprises
  • ChiNext 300
  • ChiNext Blue Chips
  • ChiNext Growth
  • ChiNext Quality
  • ChiNext Pharmaceuticals
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information